Drug Enforcement Administration, U.S. Department of Justice. (2020) Drugs of abuse: a DEA resource guide. Washington DC: Drug Enforcement Administration, U.S. Department of Justice. 2020 edition.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Drugs of abuse 2020)
7MB |
This guide is designed to be a reliable resource on the most commonly abused and misused drugs in the United States. This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects on the body and mind, overdose potential, origin, legal status, and other key facts.
B Substances > Cannabis / Marijuana
B Substances > Cannabis product (Cannabinoids)
B Substances > Hallucinogens / Psychedelics > LSD (Lysergic acid diethylamide)
B Substances > Hallucinogens / Psychedelics > Mushrooms (psilocybin)
B Substances > Inhalants and solvents
B Substances > Sedatives, hypnotics or tranquillisers (CNS depressants)
B Substances > CNS stimulants
B Substances > CNS stimulants > Amphetamines
B Substances > CNS stimulants > Methamphetamine
B Substances > CNS stimulants > MDMA / Ecstasy
B Substances > Cocaine
B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Heroin
B Substances > Steroids / performance image enhancing
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Benzodiazepines
B Substances > New (novel) psychoactive substances > Plants and extracts > Khat
B Substances > New (novel) psychoactive substances > Synthetic opioids
B Substances > New (novel) psychoactive substances > Other novel substances > GHB / GBL (Gamma hydroxybutyric / Gamma butyrolactone)
MM-MO Crime and law > Substance use laws > Drug laws
VA Geographic area > United States
Repository Staff Only: item control page